|
|
 |
|
Viewing report
|
|
|
|
Cancer Vaccines - Pipeline Analysis and Market Forecasts to 2016
GlobalData, Jan 2010, Pages: 51
Cancer Vaccines - Pipeline Analysis and Market Forecasts to 2016
Summary
GlobalData, the industry analysis specialist’s new report, “Cancer Vaccines - Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global cancer vaccines market. The report identifies the key trends shaping and driving the global cancer vaccines market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global cancer vaccines sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Our team of industry experts.
Scope
The scope of the report includes:
- Annualized global cancer vaccines market revenues data from 2000 to 2009, forecast forward for 7 years to 2016.
- Geographic markets covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.
- Analysis of the current and future market competition in the global cancer vaccines market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with cancer vaccines.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global cancer vaccines market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global cancer vaccines market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global cancer vaccines market landscape? - Identify, understand and capitalize.
Customers who bought this item also bought
Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline to Shape the Future Cancer Vaccines Market
Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018
Cervical Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018
The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact
Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
Drug Delivery in Cancer - Technologies, Markets and Companies
Adult and Adolescent Vaccines Market to 2017 - Partnerships Increase as Licensing and Co-Development Account for 73% of all Deal-Making Activity in 2010
Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and Treatment of Metastatic Cancers to Drive Drug Development
Colorectal Cancer - Italy Drug Forecasts and Treatment Analysis to 2020
Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020
|
|
|
|
